AU2012334082B2 - New coated controlled release active agent carriers - Google Patents

New coated controlled release active agent carriers Download PDF

Info

Publication number
AU2012334082B2
AU2012334082B2 AU2012334082A AU2012334082A AU2012334082B2 AU 2012334082 B2 AU2012334082 B2 AU 2012334082B2 AU 2012334082 A AU2012334082 A AU 2012334082A AU 2012334082 A AU2012334082 A AU 2012334082A AU 2012334082 B2 AU2012334082 B2 AU 2012334082B2
Authority
AU
Australia
Prior art keywords
calcium carbonate
active agent
reacted
carrier according
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012334082A
Other languages
English (en)
Other versions
AU2012334082A1 (en
Inventor
Nicola Di Maiuta
Patrick A.C. Gane
Catherine Jean Ridgway
Joachim Schoelkopf
Patrick Schwarzentruber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omya International AG
Original Assignee
Omya International AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2012334082(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya International AG filed Critical Omya International AG
Publication of AU2012334082A1 publication Critical patent/AU2012334082A1/en
Application granted granted Critical
Publication of AU2012334082B2 publication Critical patent/AU2012334082B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AU2012334082A 2011-11-10 2012-11-08 New coated controlled release active agent carriers Active AU2012334082B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11188597.6 2011-11-10
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
US201161559253P 2011-11-14 2011-11-14
US61/559,253 2011-11-14
PCT/EP2012/072161 WO2013068478A1 (en) 2011-11-10 2012-11-08 New coated controlled release active agent carriers

Publications (2)

Publication Number Publication Date
AU2012334082A1 AU2012334082A1 (en) 2014-04-24
AU2012334082B2 true AU2012334082B2 (en) 2015-10-29

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012334082A Active AU2012334082B2 (en) 2011-11-10 2012-11-08 New coated controlled release active agent carriers

Country Status (25)

Country Link
US (1) US9579291B2 (enExample)
EP (1) EP2747752B1 (enExample)
KR (1) KR101612655B1 (enExample)
CN (1) CN103957893B (enExample)
AU (1) AU2012334082B2 (enExample)
BR (1) BR112014011310B1 (enExample)
CA (1) CA2851069C (enExample)
CL (1) CL2014001172A1 (enExample)
CO (1) CO6940430A2 (enExample)
DK (1) DK2747752T3 (enExample)
ES (1) ES2553091T3 (enExample)
IL (1) IL231959A0 (enExample)
IN (1) IN2014MN00843A (enExample)
MX (1) MX346884B (enExample)
MY (1) MY168425A (enExample)
PH (1) PH12014500750A1 (enExample)
PL (1) PL2747752T3 (enExample)
PT (1) PT2747752E (enExample)
RU (2) RU2018123688A (enExample)
SG (1) SG11201401350WA (enExample)
SI (1) SI2747752T1 (enExample)
SM (1) SMT201600010B (enExample)
TW (1) TWI625129B (enExample)
WO (1) WO2013068478A1 (enExample)
ZA (1) ZA201403611B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2719376T3 (en) 2012-10-12 2015-06-15 Omya Int Ag Gastroretentiv drug formulation and delivery systems and their method of preparation by the use of functional calcium carbonate
CA2899936A1 (en) * 2013-02-15 2014-08-21 Wellmark International Mineral feed-through formulation
TR201815327T4 (tr) 2015-06-10 2018-11-21 Omya Int Ag Anti-blokaj maddesi olarak yüzeyi tepkimeye girmiş kalsiyum karbonat kullanımı.
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
AU2017229125B2 (en) 2016-03-08 2021-07-29 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
CA3074843A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Long lasting cosmetic compositions
EP3694491A1 (en) 2017-10-10 2020-08-19 Capsugel Belgium NV Gelling multiparticulates
CN111356501A (zh) 2017-11-20 2020-06-30 生活实验公司 实现持久化妆品性能的属性
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
CN112041365A (zh) 2018-04-27 2020-12-04 生活实验公司 持久性化妆品组合物
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
WO2020091456A1 (ko) * 2018-10-31 2020-05-07 ㈜아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2025132417A1 (en) 2023-12-19 2025-06-26 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631296A (en) * 1992-12-01 1997-05-20 Spirig Ag, Pharmazeutische Praeparate Drugs containing S(+)-ibuprofen
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
PL1974807T3 (pl) * 2007-03-21 2010-08-31 Omya Int Ag Sposób usuwania związków zaburzających procesy hormonalne
DE602007009124D1 (de) 2007-12-12 2010-10-21 Omya Development Ag Verfahren zur Herstellung von oberflächenreaktives Fällungskalziumkarbonat
EP2421507B1 (en) 2009-04-24 2019-01-23 Fertin Pharma A/S Chewing gum and particulate material for controlled release of active ingredients
EP2264109B1 (en) 2009-06-15 2012-01-25 Omya Development AG Process for preparing surface-reacted calcium carbonate and its use
PT2264108E (pt) 2009-06-15 2012-05-23 Omya Development Ag Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631296A (en) * 1992-12-01 1997-05-20 Spirig Ag, Pharmazeutische Praeparate Drugs containing S(+)-ibuprofen
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier

Also Published As

Publication number Publication date
RU2665382C1 (ru) 2018-08-29
SMT201600010B (it) 2016-02-25
BR112014011310A2 (pt) 2017-05-09
EP2747752A1 (en) 2014-07-02
CL2014001172A1 (es) 2014-09-12
IL231959A0 (en) 2014-05-28
WO2013068478A1 (en) 2013-05-16
NZ623515A (en) 2016-09-30
RU2018123688A3 (enExample) 2022-01-24
IN2014MN00843A (enExample) 2015-07-03
AU2012334082A1 (en) 2014-04-24
TWI625129B (zh) 2018-06-01
TW201328709A (zh) 2013-07-16
PT2747752E (pt) 2016-02-08
CO6940430A2 (es) 2014-05-09
BR112014011310B1 (pt) 2022-04-12
MX2014005466A (es) 2014-08-22
RU2018123688A (ru) 2019-03-07
US9579291B2 (en) 2017-02-28
PH12014500750A1 (en) 2014-05-12
CN103957893A (zh) 2014-07-30
EP2747752B1 (en) 2015-10-07
KR101612655B1 (ko) 2016-04-14
US20140248340A1 (en) 2014-09-04
CN103957893B (zh) 2017-08-15
MY168425A (en) 2018-11-09
ES2553091T3 (es) 2015-12-04
SI2747752T1 (sl) 2015-12-31
MX346884B (es) 2017-04-05
CA2851069C (en) 2016-05-31
KR20140091054A (ko) 2014-07-18
SG11201401350WA (en) 2014-05-29
ZA201403611B (en) 2015-07-29
PL2747752T3 (pl) 2016-04-29
CA2851069A1 (en) 2013-05-16
DK2747752T3 (en) 2016-01-18

Similar Documents

Publication Publication Date Title
AU2012334082B2 (en) New coated controlled release active agent carriers
EP2591772B1 (en) New coated controlled release active agent carriers
US10137066B2 (en) Controlled release active agent carrier
AU2015265924B2 (en) Method for the production of granules comprising surface-reacted calcium carbonate
EP3383958B1 (en) Method for the production of granules comprising surface-reacted calcium carbonate
EP2957603A1 (en) Method for the production of granules comprising surface-reacted calcium carbonate
TW202200206A (zh) 包含表面反應碳酸鈣作為賦形劑之顆粒
NZ623515B2 (en) New coated controlled release active agent carriers
EP2949708B1 (en) Method for the production of granules comprising surface-reacted calcium carbonate
AU2009299882B2 (en) New controlled release active agent carrier

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)